Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Capitol Connections Article Letco Issues Statement 10.4.13
Share |

Letco Medical Issues Response Today on Current Legislation, “Drug Quality and Security Act” (HR3204)



Letco Medical is in favor of working toward clearly defined legislation that will help further the safety and continued access of compounded preparations as well as protect the American public. Letco Medical believes that the tragic events that occurred as a result of what occurred at the New England Compounding Center were preventable and have changed the face of compounding. It is essential that any legislation address the root cause of such events and should contain clear definitions to avoid creating more confusion.

Letco Medical applauds the efforts by the International Academy of Compounding Pharmacists (IACP) and Congressional staff to work toward crafting such a bill that addresses the original intent of patient safety and clear regulatory accountability surrounding compounded preparations and the facilities that provide them.

The IACP worked closely with Congressional staff to address potential issues in “Title I: Drug Compounding” of the current legislation, “Drug Quality and Security Act” (HR 3204). The IACP identified several key problems with “Title I-Drug Compounding” of the final bill HR 3204 and issued a letter of opposition addressing these gaps in the current language.

Click here to read more.


Association Management Software Powered by YourMembership  ::  Legal